+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lymphoma Drugs Market Research Reports

US Non-Hodgkin Lymphoma Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Non-Hodgkin Lymphoma Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global Hodgkin Lymphoma Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Hodgkin Lymphoma Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Africa Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Africa Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • January 2022
  • 80 Pages
  • Africa
From
India Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

India Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • January 2022
  • 40 Pages
  • India
From
Saudi Arabia Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Saudi Arabia Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • January 2022
  • 40 Pages
  • Saudi Arabia
From
Lymphoma Treatment Drugs Markets in China - Product Thumbnail Image

Lymphoma Treatment Drugs Markets in China

  • Report
  • March 2025
  • 206 Pages
  • China
From
CAR T-Cell Therapy Market, By Type (Abecma, Breyanzi, Kymriah, Tecartus, Yescarta), End-user (Hospitals, Specialty Clinics, Others), Application (Cancer, Lymphoma, Others), Region (North America, Europe, Asia Pacific, RoW) - Global Forecast to 2028 - Product Thumbnail Image

CAR T-Cell Therapy Market, By Type (Abecma, Breyanzi, Kymriah, Tecartus, Yescarta), End-user (Hospitals, Specialty Clinics, Others), Application (Cancer, Lymphoma, Others), Region (North America, Europe, Asia Pacific, RoW) - Global Forecast to 2028

  • Report
  • June 2022
  • 220 Pages
  • Global
From
Treanda/Bendeka - Product Thumbnail Image

Treanda/Bendeka

  • Report
  • January 2019
  • 58 Pages
  • Global
From
Aliqopa - Product Thumbnail Image

Aliqopa

  • Report
  • January 2019
  • 18 Pages
  • Global
From
Treanda - API Insight, 2022 - Product Thumbnail Image

Treanda - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Velcade - API Insight, 2022 - Product Thumbnail Image

Velcade - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Beleodaq - API Insight, 2022 - Product Thumbnail Image

Beleodaq - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Mantle Cell Lymphoma Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Mantle Cell Lymphoma Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • October 2024
  • 105 Pages
  • Global
From
Indolent Lymphoma Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Indolent Lymphoma Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2024
  • 86 Pages
  • Global
From
Anaplastic Large Cell Lymphoma Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Anaplastic Large Cell Lymphoma Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2024
  • 87 Pages
  • Global
From
Diffuse Large B Cell Lymphoma Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Diffuse Large B Cell Lymphoma Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2024
  • 103 Pages
  • Global
From
Burkitt Lymphoma Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Burkitt Lymphoma Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2024
  • 99 Pages
  • Global
From
Etopophos Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Etopophos Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • August 2024
  • 84 Pages
  • Global
From
Castleman Disease Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Castleman Disease Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 93 Pages
  • Global
From
Waldenstrom Macroglobulinemia Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Waldenstrom Macroglobulinemia Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 104 Pages
  • Global
From
Loading Indicator

The Lymphoma Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat lymphoma, a type of cancer that affects the lymphatic system. These drugs are used to reduce the size of tumors, reduce symptoms, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy is the most common form of treatment for lymphoma, and involves the use of drugs to kill cancer cells. Targeted therapy is a newer form of treatment that uses drugs to target specific cancer cells, while immunotherapy uses drugs to stimulate the body's own immune system to fight the cancer. The Lymphoma Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more